Mustang Bio (MBIO) Assets Average (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Assets Average of $17.1 million for Q1 2026, up 41.12% year-over-year from $12.1 million in Q1 2025, and down 7.52% quarter-over-quarter from $18.5 million in Q4 2025.
Mustang Bio (MBIO) Assets Average (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Assets Average for 11 consecutive years, with $17.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 41.12% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $17.1 million (up 41.12% YoY), while the FY2025 annual figure was $13.5 million, down 0.55% from the prior year.
- Assets Average declined to $17.1 million in Q1 2026 per MBIO's latest filing, from $18.5 million in the prior quarter.
- Across five years, Assets Average topped out at $131.1 million in Q1 2022 and bottomed at $7.9 million in Q3 2024.
- Historically, Assets Average has averaged $45.7 million across 5 years, with a median of $18.5 million in 2025.
- Annual changes were most pronounced in 2023 — Assets Average slumped 80.97% — and 2025, when it surged 123.95%.
- Mustang Bio's Assets Average stood at $100.6 million in 2022, then plunged by 80.97% to $19.2 million in 2023, then slumped by 56.93% to $8.3 million in 2024, then surged by 123.95% to $18.5 million in 2025, then slipped by 7.52% to $17.1 million in 2026.
- Business Quant data shows MBIO's Assets Average at $17.1 million in Q1 2026, $18.5 million in Q4 2025, and $16.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 19.82 Bn |
| 10 | Mustang Bio | 3.87 Mn | 3.87 Mn | - | 16.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.10 Mn |
| Mar 31, 2026 | 17.09 Mn |
| Dec 31, 2025 | 18.48 Mn |
| Sep 30, 2025 | 16.20 Mn |
| Jun 30, 2025 | 13.98 Mn |
| Mar 31, 2025 | 12.11 Mn |
| Dec 31, 2024 | 8.25 Mn |
| Sep 30, 2024 | 7.86 Mn |
| Jun 30, 2024 | 11.56 Mn |
| Mar 31, 2024 | 16.17 Mn |
| Dec 31, 2023 | 19.15 Mn |
| Sep 30, 2023 | 24.83 Mn |
| Jun 30, 2023 | 51.35 Mn |
| Mar 31, 2023 | 83.01 Mn |
| Dec 31, 2022 | 100.63 Mn |
| Sep 30, 2022 | 115.37 Mn |
| Jun 30, 2022 | 129.43 Mn |
| Mar 31, 2022 | 131.07 Mn |
| Dec 31, 2021 | 129.94 Mn |
| Sep 30, 2021 | 138.96 Mn |